Ramesh P, Chu L
Front Cell Dev Biol. 2024; 11:1327227.
PMID: 38348091
PMC: 10859470.
DOI: 10.3389/fcell.2023.1327227.
Terhune E, Wethey C, Cuevas M, Monley A, Baschal E, Bland M
Genes (Basel). 2021; 12(6).
PMID: 34208743
PMC: 8235452.
DOI: 10.3390/genes12060922.
Han X, Xiong X, Shi X, Chen F, Li Y
Head Face Med. 2021; 17(1):17.
PMID: 34039391
PMC: 8152080.
DOI: 10.1186/s13005-021-00268-0.
Ogawa H, Sakai Y, Nishio W, Fujibayashi Y, Nishikubo M, Nishioka Y
Thorac Cancer. 2020; 11(9):2561-2569.
PMID: 32691982
PMC: 7471044.
DOI: 10.1111/1759-7714.13574.
Matsuo K, Taniguchi K, Hamamoto H, Ito Y, Futaki S, Inomata Y
Cancer Sci. 2019; 110(10):3122-3131.
PMID: 31369178
PMC: 6778628.
DOI: 10.1111/cas.14157.
Comparison of four DLL3 antibodies performance in high grade neuroendocrine lung tumor samples and cell cultures.
Brcic L, Kuchler C, Eidenhammer S, Pabst D, Quehenberger F, Gazdar A
Diagn Pathol. 2019; 14(1):47.
PMID: 31109352
PMC: 6528329.
DOI: 10.1186/s13000-019-0827-z.
Delta-like 3 is silenced by HBx via histone acetylation in HBV-associated HCCs.
Hamamoto H, Maemura K, Matsuo K, Taniguchi K, Tanaka Y, Futaki S
Sci Rep. 2018; 8(1):4842.
PMID: 29555949
PMC: 5859037.
DOI: 10.1038/s41598-018-23318-1.
UTX-guided neural crest function underlies craniofacial features of Kabuki syndrome.
Shpargel K, Starmer J, Wang C, Ge K, Magnuson T
Proc Natl Acad Sci U S A. 2017; 114(43):E9046-E9055.
PMID: 29073101
PMC: 5664495.
DOI: 10.1073/pnas.1705011114.
Relevance of genetic alterations in squamous and small cell lung cancer.
Sabari J, Paik P
Ann Transl Med. 2017; 5(18):373.
PMID: 29057233
PMC: 5635252.
DOI: 10.21037/atm.2017.06.72.
Differential expression of the Notch1 receptor, and its ligands Dll1, Dll3 and Dll4 in distinct human pituitary adenoma subtypes.
Zhang J, Gao H, Zhang Y
Oncol Lett. 2017; 13(6):4533-4539.
PMID: 28599454
PMC: 5453187.
DOI: 10.3892/ol.2017.5997.
Unravelling the biology of SCLC: implications for therapy.
Sabari J, Lok B, Laird J, Poirier J, Rudin C
Nat Rev Clin Oncol. 2017; 14(9):549-561.
PMID: 28534531
PMC: 5843484.
DOI: 10.1038/nrclinonc.2017.71.
Differential expression of the aryl hydrocarbon receptor pathway associates with craniofacial polymorphism in sympatric Arctic charr.
Ahi E, Steinhauser S, Palsson A, Franzdottir S, Snorrason S, Maier V
Evodevo. 2015; 6:27.
PMID: 26388986
PMC: 4574265.
DOI: 10.1186/s13227-015-0022-6.
A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo.
Saunders L, Bankovich A, Anderson W, Aujay M, Bheddah S, Black K
Sci Transl Med. 2015; 7(302):302ra136.
PMID: 26311731
PMC: 4934375.
DOI: 10.1126/scitranslmed.aac9459.
O-fucosylation of DLL3 is required for its function during somitogenesis.
Serth K, Schuster-Gossler K, Kremmer E, Hansen B, Marohn-Kohn B, Gossler A
PLoS One. 2015; 10(4):e0123776.
PMID: 25856312
PMC: 4391858.
DOI: 10.1371/journal.pone.0123776.
Jagged1 contributes to the drug resistance of Jurkat cells in contact with human umbilical cord-derived mesenchymal stem cells.
Yuan Y, Lu X, Chen X, Shao H, Huang S
Oncol Lett. 2013; 6(4):1000-1006.
PMID: 24137453
PMC: 3796424.
DOI: 10.3892/ol.2013.1523.
Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy.
Nwabo Kamdje A, Bassi G, Pacelli L, Malpeli G, Amati E, Nichele I
Blood Cancer J. 2012; 2(5):e73.
PMID: 22829975
PMC: 3366070.
DOI: 10.1038/bcj.2012.17.
Notch pathway regulation of neural crest cell development in vivo.
Mead T, Yutzey K
Dev Dyn. 2012; 241(2):376-89.
PMID: 22275227
PMC: 3266628.
DOI: 10.1002/dvdy.23717.
Effects of varying Notch1 signal strength on embryogenesis and vasculogenesis in compound mutant heterozygotes.
Ge C, Stanley P
BMC Dev Biol. 2010; 10:36.
PMID: 20346184
PMC: 2865454.
DOI: 10.1186/1471-213X-10-36.
Cyclical expression of the Notch/Wnt regulator Nrarp requires modulation by Dll3 in somitogenesis.
Sewell W, Sparrow D, Smith A, Gonzalez D, Rappaport E, Dunwoodie S
Dev Biol. 2009; 329(2):400-9.
PMID: 19268448
PMC: 2697309.
DOI: 10.1016/j.ydbio.2009.02.023.
The many facets of Notch ligands.
Dsouza B, Miyamoto A, Weinmaster G
Oncogene. 2008; 27(38):5148-67.
PMID: 18758484
PMC: 2791526.
DOI: 10.1038/onc.2008.229.